Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Sep. 30, 2017
Sep. 30, 2016
REVENUES    
Neurometric Services $ 128,500 $ 85,100
OPERATING EXPENSES    
Cost of neurometric services revenue 53,500 5,500
Research 123,900 53,700
Product development 1,237,200 740,500
Sales and marketing 1,226,700 522,000
General and administrative 4,590,800 2,530,200
Total operating expenses 7,232,100 3,851,900
OPERATING LOSS (7,103,600) (3,766,800)
OTHER INCOME (EXPENSE):    
Interest expense, net (6,600) (2,721,500)
Gain (loss) on extinguishment of debt 572,300
(Loss) gain on derivative liabilities (34,600)
Finance fees (20,000)
Other miscellaneous income 306,700
Legal settlement expense (275,000)
Total other expense (6,600) (2,172,100)
LOSS BEFORE PROVISION FOR INCOME TAXES (7,110,200) (5,938,900)
Provision for income taxes 2,600 2,000
NET LOSS $ (7,112,800) $ (5,940,900)
BASIC AND DILUTED LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS: (in dollars per share) $ (2.52) $ (9.26)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic and Diluted (in shares) 2,817,415 641,844